LED light between Nobel Prize and cancer risk factor

References

• AMA. (2012). AMA adopts new policies at annual meeting. Available from: http://www.ama-assn.org/ama/pub/news/news/2012-06-19-ama-adopts-new-policies.page [last accessed 1 Apr 2015]
   Google Scholar
• Bartsch H, Bartsch C. (1981). Effect of melatonin on experimental tumors under different photoperiods and times of administration. J Neural Transm. 52:269–79
   PubMed Web of Science ®Google Scholar
• Blask DE, Dauchy RT, Brainard GC, Hanifin JP. (2009). Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: Consequences of its disruption by light at night in rats and women. Integr Cancer Ther. 8:347–53
   PubMed Web of Science ®Google Scholar
• Blask DE, Dauchy RT, Sauer LA. (2005). Putting cancer to sleep at night: The neuroendocrine/circadian melatonin signal. Endocrine. 27:179–88
   PubMed Web of Science ®Google Scholar
• Brainard GC, Rollag MD, Hanifin JP. (1997). Photic regulation of melatonin in humans: Ocular and neural signal transduction. J Biol Rhythms. 12:537–46
   PubMed Web of Science ®Google Scholar
• Cajochen C, Frey S, Anders D, et al. (2011). Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance. J Appl Physiol. 110:1432–38
   PubMed Web of Science ®Google Scholar
• Chamorro E, Bonnin-Arias C, Perez-Carrasco MJ, et al. (2013). Effects of light-emitting diode radiation on human retinal pigment epithelial cells in vitro. Photochem Photobiol. 89:468–73
   PubMed Web of Science ®Google Scholar
• Crawford MH. (2009). LEDs for solid-state lighting: Performance challenges and recent advances. IEEE. 15:1028–40
   Google Scholar
• Davis S, Mirick DK, Stevens RG. (2001). Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 93:1557–62
   PubMed Web of Science ®Google Scholar
• Day TK, Bianco-Miotto T. (2013). Common gene pathways and families altered by DNA methylation in breast and prostate cancers. Endocr Relat Cancer. 20:R215–32
   PubMed Web of Science ®Google Scholar
• Erren TC, Pape HG, Reiter RJ, Piekarski C. (2008). Chronodisruption and cancer. Naturwissenschaften. 95:367–82
   PubMed Web of Science ®Google Scholar
• Falchi F, Cinzano P, Elvidge CD, et al. (2011). Limiting the impact of light pollution on human health, environment and visibility. J Environ Manage. 92:2714–22
   PubMed Web of Science ®Google Scholar
• Glickman G, Byrne B, Pineda C, et al. (2005). Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry. 59:502–7
   PubMed Web of Science ®Google Scholar
• Haim A, Portnov BA. (2013). Light pollution as a new risk factor for human breast and prostate cancers. Dordrecht, Heidelberg, New York, London: Springer
   Google Scholar
• Haim A, Yukler A, Harel O, et al. (2010). Effects of chronobiology on prostate cancer cells growth in vivo. Sleep Sci 3:32–5
   Google Scholar
• Haim A, Zubidat AE. (2014). Artificial light at night – Melatonin as a mediator between the environment and epigenome. Trans R Soc B. 370:20140121
   Web of Science ®Google Scholar
• Hanifin JP, Stewart KT, Smith P, et al. (2006). High-intensity red light suppresses melatonin. Chronobiol Int. 23:251–68
   PubMed Web of Science ®Google Scholar
• Hattori N, Ushijima T. (2014). Compendium of aberrant DNA methylation and histone modifications in cancer. Biochem Biophys Res Commun. 455:3–9
   PubMed Web of Science ®Google Scholar
• Jaenisch R, Bird A. (2003). Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet. 33:245–54
   PubMed Web of Science ®Google Scholar
• Kloog I, Haim A, Stevens RG, et al. (2008). Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int. 25:65–81
   PubMed Web of Science ®Google Scholar
• Leonardi GC, Rapisarda V, Marconi A, et al. (2012). Correlation of the risk of breast cancer and disruption of the circadian rhythm. Oncol Rep. 28:418–28
   PubMed Web of Science ®Google Scholar
• Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, et al. (2010). Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem. 17:4462–81
   PubMed Web of Science ®Google Scholar
• Nelson RJ. (2005). An introduction to behavioral endocrinology. Sunderland, MA: Sinauer Association, Inc
   Google Scholar
• Proietti S, Cucina A, Reiter RJ, Bizzarri M. (2013). Molecular mechanisms of melatonin's inhibitory actions on breast cancers. Cell Mol Life Sci. 70:2139–57
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Laden F, Speizer FE, et al. (2001). Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 93:1563–68
   PubMed Web of Science ®Google Scholar
• Schwimmer H, Metzer A, Pilosof Y, et al. (2014). Light at night and melatonin have opposite effects on breast cancer tumours in mice assessed by growth rates and global DNA methylation. Chronobiol Int. 31:144–50
   PubMed Web of Science ®Google Scholar
• Shah PN, Mhatre MC, Kothari LS. (1984). Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res. 44:3403–7
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Pandi-Perumal SR, Brzezinski A, et al. (2011). Melatonin, immune function and cancer. Recent Pat Endocr Metab Immune Drug Discov. 5:109–23
   Google Scholar
• Srinivasan V, Spence DW, Pandi-Perumal SR, et al. (2008). Melatonin, environmental light, and breast cancer. Breast Cancer Res Treat 108:339–50
   PubMed Web of Science ®Google Scholar
• Tamarkin L, Cohen M, Roselle D, et al. (1981). Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res. 41:4432–6
   PubMed Web of Science ®Google Scholar
• Thapan K, Arendt J, Skene DJ. (2001). An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol. 535:261–7
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Hankinson SE, Schernhammer ES. (2007). Night shift work and the risk of endometrial cancer. Cancer Res. 67:10618–22
   PubMed Web of Science ®Google Scholar
• Wang F, Yeung KL, Chan WC, et al. (2013). A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer. Ann Oncol. 24:2724–32
   PubMed Web of Science ®Google Scholar
• West KE, Jablonski MR, Warfield B, et al. (2011). Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. J Appl Physiol. 110:619–26
   PubMed Web of Science ®Google Scholar
• Wu J, Dauchy RT, Tirrell PC, Wu SS, et al. (2011). Light at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast cancer xenografts. Cancer Res. 71:2622–31
   PubMed Web of Science ®Google Scholar
• Xiang TX, Yuan Y, Li LL, et al. (2013). Aberrant promoter CpG methylation and its translational applications in breast cancer. Chin J Cancer. 32:12–20
   PubMedGoogle Scholar
• Yang WS, Deng Q, Fan WY, et al. (2014). Light exposure at night, sleep duration, melatonin, and breast cancer: A dose-response analysis of observational studies. Eur J Cancer Prev. 23:269–76
   PubMed Web of Science ®Google Scholar
• Zubidat AE, Nelson RJ, Haim A. (2011). Spectral and duration sensitivity to light-at-night in ‘blind' and sighted rodent species. J Exp Biol. 214:3206–17
   PubMed Web of Science ®Google Scholar